iGaming B2B
Founded
2015-01-01 in Spain
Headquarters
Physical Address:, Mailing Address:, Calle Impresores, 20 Parque Empresarial Prado del Espino 28660 Boadilla del Monte, Madrid, Madrid, Spain, Calle Impresores, 20 Parque Empresarial Prado del Espi, Madrid, Spain
Email
info@narrativa.com

Narrativa is an agentic AI platform purpose-built for the life sciences industry, enabling pharmaceutical and biotech organizations to generate complex, high-volume documentation at scale. Founded in 2015 by serial entrepreneur David Llorente, the company emerged from a recognition that businesses were struggling to measure and scale content creation effectively. Llorente and his team developed foundational innovations including a proprietary knowledge graph and a pseudo-programming language for text generation, which evolved into the Narrativa Navigator platform. Today, Narrativa focuses exclusively on regulated environments, automating the creation of clinical study reports, patient safety narratives, regulatory submissions, and commercial content. The platform is designed to meet strict compliance standards, including GxP-readiness, GDPR, HIPAA, and alignment with FDA/EMA guidance and the EU AI Act. In 2023, Narrativa became the first AI vendor to fully automate patient safety narratives for an FDA-submitted study with 100% data accuracy, and in 2025 it generated more than 65,000 regulatory compliance documents for pharmaceutical companies across multiple markets. The company has been recognized by Microsoft (Microsoft for Startups, 2020), Google (Google for Startups, 2023), and Samsung (Synthetic Media Landscape, 2020). Narrativa’s client base includes top-tier pharmaceutical firms, and it has expanded into veterinary regulatory documentation through a partnership with VMD Sciences in 2026.

Detailed Review

Company History and Founding

Narrativa was founded in 2015 by David Llorente, who after a previous successful venture recognized the difficulty businesses faced in measuring and scaling content creation. The company initially developed a proprietary knowledge graph and a pseudo-programming language for text generation, which later formed the core of its content automation platform. Early work included a notable research project with Spain’s public broadcaster RTVE from 2021 to 2024, where Narrativa’s technology autonomously generated election news for nearly 5,000 small municipalities, demonstrating its versatility beyond life sciences.

Platform and Products

The flagship product is Narrativa Navigator, an AI-powered content automation engine that transforms raw clinical and commercial data into structured, human-quality narratives. The platform is built with a validation-ready architecture for GxP-regulated workflows and incorporates a risk-based AI safety framework aligned with FDA/EMA guidance and the EU AI Act. Narrativa’s offerings are divided into two primary workflows: Regulatory and Commercialization. The regulatory suite automates high-volume documentation such as clinical study reports (CSRs), patient safety narratives, tables, listings, and figures (TLFs), and eCTD submission-ready content. The commercialization side supports rapid generation of marketing materials, white papers, and product communications for drug launches and market access. A Spanish-language version of Narrativa Navigator is also available, enabling full functionality in Spanish.

Regulatory and Compliance Milestones

Narrativa achieved a landmark in 2023 by becoming the first AI vendor to fully automate patient safety narratives for an FDA-submitted study with 100% data accuracy. In 2025, the platform generated over 65,000 regulatory compliance documents for pharmaceutical companies across multiple markets. The company emphasizes data privacy and security, maintaining HIPAA-ready architecture and GDPR compliance. In 2026, Narrativa expanded into veterinary regulatory documentation through a partnership with VMD Sciences, further broadening its regulated content capabilities.

Market Position and Partnerships

Narrativa has been recognized by major technology firms: Microsoft (Microsoft for Startups, 2020), Google (Google for Startups, 2023), and Samsung (Synthetic Media Landscape, 2020). Its client base includes top-tier pharmaceutical companies. The company also collaborates with regulatory bodies; in 2026, President Jennifer Bittinger became the first AI vendor representative on the CDISC Board, influencing AI compliance and standardization in clinical research. Narrativa operates at the intersection of AI and life sciences compliance, with competitors including other RegTech and content automation providers, though its focus on agentic AI for regulated documentation sets it apart.

Leadership and Team

The company is led by CEO and Co-Founder David Llorente, who has a background as a serial entrepreneur. Jennifer Bittinger serves as President and made history by joining the CDISC Board in 2026. Other C-level roles include a CTO & Co-Founder, Chief Data Scientist & Co-Founder, CSO, and CFO, whose names are not publicly disclosed. The team also includes a VP of Content and Head of Operations. Narrativa’s expertise spans AI research, content strategy, and regulatory affairs.

Key Products

  • Narrativa Navigator

    AI-powered content automation platform for generating regulatory and commercial documentation in life sciences. Supports creation of clinical study reports, patient narratives, TLFs, and eCTD submissions. Features a user guide for automating content generation via configurable workflows.

  • Agentic AI Solutions for Regulatory

    Specialized AI agents that analyze clinical data and produce structured narratives, reducing manual effort and ensuring compliance with FDA/EMA standards.

  • Agentic AI Solutions for Commercialization

    Automated generation of marketing materials, white papers, and product communication for pharmaceutical and biotech companies.

  • Narrativa Navigator (Spanish Version)

    Localized version of the platform enabling creation, customization, and editing of narratives entirely in Spanish, with a Spanish-language user interface.

Key Persons

Related Companies